Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4)

Am Heart J. 2003 Feb;145(2 Suppl):S58-9. doi: 10.1067/mhj.2003.156.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Double-Blind Method
  • Endothelin Receptor Antagonists
  • Endothelin-1 / antagonists & inhibitors*
  • Endothelin-1 / physiology
  • Heart Failure / drug therapy*
  • Heart Failure / etiology
  • Humans
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / drug therapy*
  • Pyridines / therapeutic use*
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin / physiology
  • Recurrence
  • Tetrazoles / therapeutic use*
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use*

Substances

  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Pyridines
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin
  • Tetrazoles
  • Vasodilator Agents
  • tezosentan